Evidence map›Paper›PMID 40676214›Full record

ArticleThe EMBO journal2025

Master transcription-factor binding sites constitute the core of early replication control elements.

Jesse L Turner, Laura Hinojosa-Gonzalez, Takayo Sasaki, Satoshi Uchino, Athanasios Vouzas, Mariella S Soto, Abhijit Chakraborty, Karen E Alexander, Cheryl A Fitch, Amber N Brown and 2 more

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. A CThe New phytologist · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jesse L Turner *Department of Biological Science, Florida State University, Tallahassee, FL, 32306, USA.ORCID http://orcid.org/0000-0003-1149-5160
Laura Hinojosa-Gonzalez *La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0009-0006-3812-887X
Takayo SasakiSan Diego Biomedical Research Institute, San Diego, CA, 92121, USA.ORCID http://orcid.org/0000-0001-7609-9316
Satoshi UchinoSan Diego Biomedical Research Institute, San Diego, CA, 92121, USA.ORCID http://orcid.org/0000-0003-1444-0130
Athanasios VouzasDepartment of Biological Science, Florida State University, Tallahassee, FL, 32306, USA.
Mariella S SotoSan Diego Biomedical Research Institute, San Diego, CA, 92121, USA.ORCID http://orcid.org/0009-0000-7707-1542
Abhijit ChakrabortyLa Jolla Institute for Immunology, La Jolla, CA, 92037, USA.
Karen E AlexanderDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL, 32306, USA.
Cheryl A FitchDepartment of Biological Science, Florida State University, Tallahassee, FL, 32306, USA.
Amber N BrownDepartment of Biological Science, Florida State University, Tallahassee, FL, 32306, USA.ORCID http://orcid.org/0000-0003-1171-5346
Ferhat AyLa Jolla Institute for Immunology, La Jolla, CA, 92037, USA. ferhatay@lji.org.ORCID http://orcid.org/0000-0002-0708-6914
David M GilbertSan Diego Biomedical Research Institute, San Diego, CA, 92121, USA. gilbert@sdbri.org.ORCID http://orcid.org/0000-0001-8087-9737

Funding

Genome Plasticity during ES Cell Differentiation to Neural LineagesR01GM083337 · NIGMS · SAN DIEGO BIOMEDICAL RESEARCH INSTITUTE · PI David M Gilbert · 2007 to 2026
$6.1M
Studying the function of human genetic variation in the light of 3D genome organizationR35GM128938 · NIGMS · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Ferhat Ay · 2018 to 2026
$4.6M
Graduate Training Program in BioinformaticsT32GM139790 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAFNA, VINEET, GAASTERLAND, THERESA · 2021 to 2025
$2.1M
Genetic dissection of cis-acting elements controlling DNA replication timing and genome architectureF31AG066481 · NIA · FLORIDA STATE UNIVERSITY · PI TURNER, JESSE LLOYD · 2020 to 2021
$81k
HHS | NIH | National Institute of General Medical Sciences (NIGMS) R01-GM083337HHS | NIH | National Institute of General Medical Sciences (NIGMS) R35-GM128938HHS | NIH | National Institute of General Medical Sciences (NIGMS) T32-GM139790HHS | NIH | National Institute on Aging (NIA) F31-AG066481NIA NIH HHS F31 AG066481NIGMS NIH HHS R01 GM083337NIGMS NIH HHS R35 GM128938NIGMS NIH HHS T32 GM139790
6 · The paper itself

Abstract

Eukaryotic genomes replicate in a defined temporal order called the replication timing (RT) program. RT is developmentally regulated with the potential to drive cell fate transitions, but mechanisms controlling RT remain elusive. We previously identified "Early Replication Control Elements" (ERCEs), cis-acting elements necessary for early RT, domain-wide transcription, 3D chromatin architecture and compartmentalization in mouse embryonic stem cells (mESCs), but deletions identifying ERCEs were large and encompassed many putative regulatory elements. Here, we show that ERCEs are compound elements, whose RT activity can largely be accounted for by multiple binding sites for diverse master transcription factors (subERCEs). While deletion of subERCEs had large effects on both transcription and replication timing, deleting transcription start sites eliminated nearly all transcription with only moderate effects on replication timing. Our results suggest a model in which subERCEs are a class of transcriptional enhancers that can also organize chromatin domains structurally to support early replication timing, potentially providing a feed-forward loop to drive robust epigenomic change during cell fate transitions.

Indexed as

DNA ReplicationDNA Replication TimingMouse Embryonic Stem CellsTranscription FactorsAnimalsBinding SitesChromatinMiceTranscription, GeneticChromatinTranscription FactorsCell CycleCell fate TransitionsGenome ArchitectureReplication TimingTranscription

Identifiers

PMID40676214
PMCPMC12361434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.